Medispray Laboratories Private Limited — Salbutamol Exporter Profile
Indian Pharmaceutical Exporter · #4 for Salbutamol · $4.9M export value · DGFT Verified
Medispray Laboratories Private Limited is the #4 Indian exporter of Salbutamol with $4.9M in export value and 177 verified shipments. Medispray Laboratories Private Limited holds a 3.3% market share in Salbutamol exports across 2 countries. The company exports 7 pharmaceutical products worth $16.4M across 2 therapeutic categories.
Medispray Laboratories Private Limited — Salbutamol Export Profile: Buyers & Destinations

Where Does Medispray Laboratories Private Limited Export Salbutamol?
Medispray Laboratories Private Limited exports Salbutamol to 2 countries. The largest destination is MALAYSIA accounting for 82.1% of Medispray Laboratories Private Limited's Salbutamol shipments. These destinations reflect Medispray Laboratories Private Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Salbutamol from Medispray Laboratories Private Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| CIPLA MALAYSIA SDN BHD | MALAYSIA | $3.4M | 130 |
| CIPLA MALAYSIA SDN BHD, | MALAYSIA | $819.7K | 29 |
| TECNOQUIMICAS S A | COLOMBIA | $391.2K | 11 |
| TECNOQUIMICAS S.A. | COLOMBIA | $236.1K | 6 |
| TECNOQUIMICAS SA | COLOMBIA | $107.2K | 3 |
| TECNOQUIMICAS S,A, | COLOMBIA | $102.6K | 3 |
| LAFRANCOL INTERNACIONAL S A S Y O | COLOMBIA | $37.4K | 1 |
| LAFRANCOL INTERNACIONAL S.A.S | COLOMBIA | $36.0K | 1 |
Medispray Laboratories Private Limited supplies Salbutamol to 8 buyers globally. The largest buyer is CIPLA MALAYSIA SDN BHD (MALAYSIA), followed by CIPLA MALAYSIA SDN BHD, (MALAYSIA) and TECNOQUIMICAS S A (COLOMBIA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Salbutamol Export Value and How Much Does Medispray Laboratories Private Limited Contribute?
India exported $130.8M worth of Salbutamol through 14,359 shipments from 602 suppliers to 164 countries, serving 1,775 buyers globally. Medispray Laboratories Private Limited contributes $4.9M to this total, accounting for 3.3% of India's Salbutamol exports. Medispray Laboratories Private Limited ships Salbutamol to 2 countries through 8 buyers.
What Is the Average Shipment Value for Medispray Laboratories Private Limited's Salbutamol Exports?
Medispray Laboratories Private Limited's average Salbutamol shipment value is $27.5K per consignment, based on 177 shipments totaling $4.9M. The largest destination is MALAYSIA (82.1% of Medispray Laboratories Private Limited's Salbutamol exports).
How Does Medispray Laboratories Private Limited Compare to Other Indian Salbutamol Exporters?
Medispray Laboratories Private Limited ranks #4 among 602 Indian Salbutamol exporters with a 3.3% market share. The top 3 exporters are CIPLA LIMITED ($100.3M), GLENMARK PHARMACEUTICALS LIMITED ($5.7M), AHLCON PARENTERALS (INDIA) LIMITED ($4.9M). Medispray Laboratories Private Limited processed 177 shipments to 2 destination countries.
What Salbutamol Formulations Does Medispray Laboratories Private Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| ASTHALIN 100 MCG INHALER (SALBUTAMOL SUL | $1.7M | 50 |
| ASTHALIN 100MCG INHALER (SALBUTAMOL SULPHATE ) (1 X 200 MD) | $1.2M | 35 |
| ASTHALIN 100 MCG INHALER (SALBUTAMOL SULPHATE ) . | $660.3K | 47 |
| ASTHALIN 100 MCG INHALER SALBUTAMOL SULPHATE . | $310.5K | 10 |
| SALBUTAMOL 100 MCG INH CFC FREE SALBUTA | $214.6K | 6 |
| SALBUTAMOL 100 MCG INH CFC FREE SALBUTAMOL INHALER 100 MCG 200 MD | $214.3K | 6 |
| ASTHALIN 100 MCG INHALER SALBUTAMOL SUL | $141.0K | 8 |
| ASTHALIN 100 MCG INHALER (SALBUTAMOL SULPHATE ) (1 X 200 MD) . | $136.9K | 8 |
| SALBUTAMOL 100 MCG INH CFC FREE (SALBUTAMOL INHALER 100 MCG (200 MD) | $107.0K | 3 |
| SALBUTAMOL 100 MCG INH CFC FREE (SALBUTA | $102.6K | 3 |
Medispray Laboratories Private Limited exports 16 distinct Salbutamol formulations including tablets, capsules, syrups, and combination drugs. The top formulation is ASTHALIN 100 MCG INHALER (SALBUTAMOL SUL with 50 shipments worth $1.7M.
How Does Medispray Laboratories Private Limited Compare to Nearest Salbutamol Exporters?
Exporters ranked immediately above and below #4 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 2 | GLENMARK PHARMACEUTICALS LIMITED | $5.7M | 298 | 11 | $19.3K |
| 3 | AHLCON PARENTERALS (INDIA) LIMITED | $4.9M | 117 | 4 | $42.1K |
| 4 | MEDISPRAY LABORATORIES PRIVATE LIMITED ★ | $4.9M | 177 | 2 | $27.5K |
| 6 | EMCURE PHARMACEUTICALS LIMITED | $2.2M | 123 | 14 | $18.1K |
| 7 | AMANTA HEALTHCARE LIMITED | $2.0M | 43 | 4 | $46.3K |
Medispray Laboratories Private Limited ranks #4 among 602 Indian Salbutamol exporters. Average shipment value of $27.5K compared to the market average of $217.4K. The closest competitors by value are GLENMARK PHARMACEUTICALS LIMITED and AHLCON PARENTERALS (INDIA) LIMITED.
Which Indian Ports Ship Salbutamol Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 2,198 | 15.3% |
| SAHAR AIR | 2,141 | 14.9% |
| DELHI AIR CARGO ACC (INDEL4) | 1,530 | 10.7% |
| NHAVA SHEVA SEA (INNSA1) | 1,497 | 10.4% |
| DELHI AIR | 1,064 | 7.4% |
| JNPT/ NHAVA SHEVA SEA | 1,036 | 7.2% |
| JNPT | 842 | 5.9% |
| Bombay Air | 568 | 4.0% |
What Other Respiratory Products Does Medispray Laboratories Private Limited Export?
Medispray Laboratories Private Limited also exports these respiratory products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on Medispray Laboratories Private Limited's Salbutamol Exports
The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Medispray Laboratories. The Israel-Iran conflict has led to disruptions in Red Sea shipping routes, causing increased freight costs and extended transit times. These disruptions are particularly impactful for time-sensitive pharmaceutical shipments, potentially affecting Medispray's supply chain efficiency. (pharmaceuticalcommerce.com)
Conversely, escalating trade tensions between the U.S. and China have prompted the U.S. to seek alternative sources for pharmaceuticals, potentially opening avenues for Indian exporters. However, recent U.S. tariff policies, including a 25% tariff on Indian imports due to India's purchase of Russian oil, pose a significant challenge. These tariffs could affect nearly 55% of India's exports to the U.S., impacting companies like Medispray that rely on the American market. (apnews.com)
In the European Union, stringent regulatory changes, such as the Falsified Medicines Directive, necessitate compliance with advanced serialization and traceability requirements. For Medispray, adhering to these regulations is crucial to maintain and expand its presence in the EU market.
Medispray Laboratories Private Limited — Regulatory Compliance & Quality Standards
The global pharmaceutical industry is witnessing heightened regulatory scrutiny, with agencies like the USFDA intensifying inspections and compliance requirements. Medispray's recent VAI classification from the USFDA indicates a need for continuous improvement in quality management systems to meet international standards. (business-standard.com)
Additionally, the World Health Organization (WHO) and the European Medicines Agency (EMA) are enforcing stricter Good Manufacturing Practice (GMP) guidelines. For Medispray, aligning with these evolving standards is imperative to ensure product quality, patient safety, and sustained market access.
About Medispray Laboratories Private Limited
Medispray Laboratories Private Limited exports 7 products worth $16.4M. Beyond Salbutamol, top products include Citalopram, Escitalopram, Salmeterol, Fluticasone, Formoterol. View the complete Medispray Laboratories Private Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Salbutamol — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Salbutamol shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Medispray Laboratories Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 184 individual customs records matching Medispray Laboratories Private Limited exporting Salbutamol, covering 16 formulations to 2 countries via 8 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 164+ countries, 1,775+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Salbutamol Export Data from Medispray Laboratories Private Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Medispray Laboratories Private Limited's Salbutamol exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Medispray Laboratories Private Limited
Full Company Profile →
7 products · $16.4M total trade · 2 categories
Salbutamol Stats
Company Overview
Top Products by Medispray Laboratories Private Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Medispray Laboratories Private Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Salbutamol. For current shipment-level data, contact TransData Nexus.